-
Kalydeco Use In Utero Could Slow CF Progression, Animal Study Finds
An animal model of cystic fibrosis treated with Kalydeco in utero and after birth showed that early treatment could help slow CF progression. Read more about it.
What do you think of this news?
Sorry, there were no replies found.
Log in to reply.